BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Peineau S, Rabiant K, Pierrefiche O, Potier B. Synaptic plasticity modulation by circulating peptides and metaplasticity: Involvement in Alzheimer's disease. Pharmacol Res 2018;130:385-401. [PMID: 29425728 DOI: 10.1016/j.phrs.2018.01.018] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Mhaouty-Kodja S, Belzunces LP, Canivenc MC, Schroeder H, Chevrier C, Pasquier E. Impairment of learning and memory performances induced by BPA: Evidences from the literature of a MoA mediated through an ED. Mol Cell Endocrinol 2018;475:54-73. [PMID: 29605460 DOI: 10.1016/j.mce.2018.03.017] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
2 Dulewicz M, Kulczyńska-Przybik A, Słowik A, Borawska R, Mroczko B. Neurogranin and Neuronal Pentraxin Receptor as Synaptic Dysfunction Biomarkers in Alzheimer's Disease. J Clin Med 2021;10:4575. [PMID: 34640593 DOI: 10.3390/jcm10194575] [Reference Citation Analysis]
3 Um YH, Lim HK. Orexin and Alzheimer's Disease: A New Perspective. Psychiatry Investig 2020;17:621-6. [PMID: 32517419 DOI: 10.30773/pi.2020.0136] [Reference Citation Analysis]
4 Mango D, Saidi A, Cisale GY, Feligioni M, Corbo M, Nisticò R. Targeting Synaptic Plasticity in Experimental Models of Alzheimer's Disease. Front Pharmacol 2019;10:778. [PMID: 31379566 DOI: 10.3389/fphar.2019.00778] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 8.0] [Reference Citation Analysis]
5 Popović N, Morales-Delgado N, Vidal Mena D, Alonso A, Pascual Martínez M, Caballero Bleda M, Popović M. Verapamil and Alzheimer's Disease: Past, Present, and Future. Front Pharmacol 2020;11:562. [PMID: 32431612 DOI: 10.3389/fphar.2020.00562] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
6 Gu X, Wu H, Xie Y, Xu L, Liu X, Wang W. Caspase-1/IL-1β represses membrane transport of GluA1 by inhibiting the interaction between Stargazin and GluA1 in Alzheimer's disease. Mol Med 2021;27:8. [PMID: 33509083 DOI: 10.1186/s10020-021-00273-8] [Reference Citation Analysis]
7 Hunter S, Brayne C. Amyloid in the ageing brain: New frameworks and perspectives. Aging Brain 2021;1:100008. [DOI: 10.1016/j.nbas.2021.100008] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Nisticò R, Peineau S. Alzheimer's disease: understanding homeostasis deregulation to foster development of effective therapies. Pharmacol Res 2019;139:467-8. [PMID: 30553822 DOI: 10.1016/j.phrs.2018.12.011] [Reference Citation Analysis]
9 Yang G, Zhu J, Zhan G, Fan G, Deng L, Tang H, Jiang X, Chen B, Yang C. Mesenchymal Stem Cell-Derived Neuron-Like Cell Transplantation Combined with Electroacupuncture Improves Synaptic Plasticity in Rats with Intracerebral Hemorrhage via mTOR/p70S6K Signaling. Stem Cells Int 2022;2022:6450527. [PMID: 35211177 DOI: 10.1155/2022/6450527] [Reference Citation Analysis]
10 Wang JKT. Uniting homeostatic plasticity and exosome biology: A revision of the conceptual framework for drug discovery in neurodegenerative diseases? Adv Pharmacol 2021;90:277-306. [PMID: 33706937 DOI: 10.1016/bs.apha.2020.10.002] [Reference Citation Analysis]
11 Poon CH, Tse LSR, Lim LW. DNA methylation in the pathology of Alzheimer's disease: from gene to cognition. Ann N Y Acad Sci 2020;1475:15-33. [PMID: 32491215 DOI: 10.1111/nyas.14373] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
12 Hofford RS, Russo SJ, Kiraly DD. Neuroimmune mechanisms of psychostimulant and opioid use disorders. Eur J Neurosci 2019;50:2562-73. [PMID: 30179286 DOI: 10.1111/ejn.14143] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 7.3] [Reference Citation Analysis]
13 Zhang X, Zhao F, Wang C, Zhang J, Bai Y, Zhou F, Wang Z, Wu M, Yang W, Guo J, Qi J. AVP(4-8) Improves Cognitive Behaviors and Hippocampal Synaptic Plasticity in the APP/PS1 Mouse Model of Alzheimer's Disease. Neurosci Bull 2020;36:254-62. [PMID: 31605298 DOI: 10.1007/s12264-019-00434-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
14 Jeremic D, Jiménez-Díaz L, Navarro-López JD. Past, present and future of therapeutic strategies against amyloid-β peptides in Alzheimer's disease: a systematic review. Ageing Res Rev 2021;72:101496. [PMID: 34687956 DOI: 10.1016/j.arr.2021.101496] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Nour H, Abchir O, Belaidi S, Qais FA, Chtita S, Belaaouad S. 2D‐QSAR and molecular docking studies of carbamate derivatives to discover novel potent anti‐butyrylcholinesterase agents for Alzheimer's disease treatment. Bulletin Korean Chem Soc. [DOI: 10.1002/bkcs.12449] [Reference Citation Analysis]
16 Djebari S, Iborra-Lázaro G, Temprano-Carazo S, Sánchez-Rodríguez I, Nava-Mesa MO, Múnera A, Gruart A, Delgado-García JM, Jiménez-Díaz L, Navarro-López JD. G-Protein-Gated Inwardly Rectifying Potassium (Kir3/GIRK) Channels Govern Synaptic Plasticity That Supports Hippocampal-Dependent Cognitive Functions in Male Mice. J Neurosci 2021;41:7086-102. [PMID: 34261700 DOI: 10.1523/JNEUROSCI.2849-20.2021] [Reference Citation Analysis]
17 García-Aviles JE, Méndez-Hernández R, Guzmán-Ruiz MA, Cruz M, Guerrero-Vargas NN, Velázquez-Moctezuma J, Hurtado-Alvarado G. Metabolic Disturbances Induced by Sleep Restriction as Potential Triggers for Alzheimer's Disease. Front Integr Neurosci 2021;15:722523. [PMID: 34539357 DOI: 10.3389/fnint.2021.722523] [Reference Citation Analysis]
18 Garad M, Edelmann E, Leßmann V. Impairment of Spike-Timing-Dependent Plasticity at Schaffer Collateral-CA1 Synapses in Adult APP/PS1 Mice Depends on Proximity of Aβ Plaques. Int J Mol Sci 2021;22:1378. [PMID: 33573114 DOI: 10.3390/ijms22031378] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
19 Jeremic D, Sanchez-Rodriguez I, Jimenez-Diaz L, Navarro-Lopez JD. Therapeutic potential of targeting G protein-gated inwardly rectifying potassium (GIRK) channels in the central nervous system. Pharmacol Ther 2021;223:107808. [PMID: 33476640 DOI: 10.1016/j.pharmthera.2021.107808] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]